Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 1,985.30
-45.40 (-2.24%)
Sep 26, 2025, 9:30 AM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 573.07 billion as of September 25, 2025. Its market cap has increased by 19.16% in one year.
Market Cap
573.07B
Enterprise Value
580.74B
Revenue
134.56B
Ranking
n/a
PE Ratio
76.06
Stock Price
1,985.30
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 573.07B, an increase of 49,761.97%. That is a compound annual growth rate of 29.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2025 | 573.07B | 26.21% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | 139.25B | 42.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,903.96B |
| Divi's Laboratories | 1,588.56B |
| Cipla | 1,242.33B |
| Apollo Hospitals Enterprise | 1,099.02B |
| Mankind Pharma | 1,044.16B |
| Zydus Lifesciences | 1,042.46B |
| Fortis Healthcare | 725.06B |
| Alkem Laboratories | 662.93B |